Bo Zhai
机构：Zhejiang Chinese Medical University, Renji Hospital, Shanghai Cancer Institute, Shanghai East Hospital, State Key Laboratory of Oncogene and Related Genes, Huainan Mining Industry Group (China) · ORCID：0000-0003-4337-7126
发表论文 249 篇 · 总被引 8687 次 · h-index 47
代表论文
- Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy (2023 · 癌症：英文版 · 被引 32)
- IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment (2025 · Journal of Translational Medicine · 被引 27)
- Anticancer therapy-induced adverse drug reactions in children and preventive and control measures (2024 · Frontiers in Pharmacology · 被引 22)
- Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects (2023 · Liver Research · 被引 20)
- Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition) ∆ (2024 · Journal of Cancer Research and Therapeutics · 被引 18)
- Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial (2024 · Signal Transduction and Targeted Therapy · 被引 17)